Marker Therapeutics, Inc.

Tagged: biotech 2017

TapImmune to Present at 2017 Biotechnology Innovation Organization International Convention

Dr. Glynn Wilson, Chairman and CEO of TapImmune, will present at the 2017 Biotechnology Innovation Organization International Convention held on June 19-22 in San Diego.

Read More

TapImmune To Present At Biotech Showcase 2017

TapImmune, Inc. (NASDAQ: TPIV), today announced its Chairman and CEO, Dr. Glynn Wilson, will present at Biotech Showcase 2017 to be held January 9-11, 2017, at the Hilton San Francisco Union Square.

Read More